Kisqali (200 MG Dose) and Peginterferon alfa-2a Subcutaneous
Determining the interaction of Kisqali (200 MG Dose) and Peginterferon alfa-2a Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ribociclib
Brand name: Kisqali
Synonyms: Kisqali
Generic Name: peginterferon alfa-2a
Brand name: Pegasys, Pegasys ProClick Autoinjector, Pegasys Prefilled Syringe
Synonyms: Peginterferon alfa-2a, Peginterferon Alfa-2a
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Kisqali (200 MG Dose)-Peginterferon alfa-2b
- Kisqali (200 MG Dose)-Peginterferon Alfa-2b (Peg-Intron)
- Kisqali (200 MG Dose)-Peginterferon Alfa-2b (Sylatron)
- Kisqali (200 MG Dose)-Peginterferon alfa-2b Subcutaneous
- Kisqali (200 MG Dose)-Peginterferon beta-1a
- Kisqali (200 MG Dose)-Peginterferon beta-1a Subcutaneous
- Peginterferon alfa-2a Subcutaneous-Kisqali (400 MG Dose)
- Peginterferon alfa-2a Subcutaneous-Kisqali (600 MG Dose)
- Peginterferon alfa-2a Subcutaneous-Kisqali Femara Co-Pack
- Peginterferon alfa-2a Subcutaneous-Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
- Peginterferon alfa-2a Subcutaneous-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Peginterferon alfa-2a Subcutaneous-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose